TY - JOUR
T1 - Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia
AU - Oda, Tsukasa
AU - Heaney, Conor
AU - Hagopian, John R.
AU - Okuda, Keiko
AU - Griffin, James D.
AU - Druker, Brian J.
PY - 1994/9/16
Y1 - 1994/9/16
N2 - The Philadelphia chromosome (Ph1), detected in virtually all cases of chronic myelogenous leukemia (CML), is formed by a reciprocal translocation between chromosome 9 and 22 that fuses Bcr-encoded sequences upstream of exon 2 of c-Abl. This oncogene produces a fusion protein, p210(bcr-abl), in which the Abl tyrosine kinase activity is elevated. Using anti-phosphotyrosine immunoblotting, we have compared the pattern of phosphotyrosine-containing proteins from freshly prepared neutrophils of patients in the stable phase of CML to normal controls. The only consistent difference was the presence of a 39-kDa tyrosine-phosphorylated protein in 18 out of 18 neutrophil samples from CML patients that was not seen in normal controls. This same protein, as assessed by two-dimensional anti-phosphotyrosine immunoblotting, was also present in cell lines expressing p210(bcr-abl), including K562 cells. Using K562 cells as a source of protein, the 39-kDa protein was purified and identified by microsequencing as Crkl, an SH2/SH3 adaptor protein related to the crk oncogene of the avian sarcoma virus, CT10. A direct interaction between Crkl and Abl has also been shown using a yeast two-hybrid screen.
AB - The Philadelphia chromosome (Ph1), detected in virtually all cases of chronic myelogenous leukemia (CML), is formed by a reciprocal translocation between chromosome 9 and 22 that fuses Bcr-encoded sequences upstream of exon 2 of c-Abl. This oncogene produces a fusion protein, p210(bcr-abl), in which the Abl tyrosine kinase activity is elevated. Using anti-phosphotyrosine immunoblotting, we have compared the pattern of phosphotyrosine-containing proteins from freshly prepared neutrophils of patients in the stable phase of CML to normal controls. The only consistent difference was the presence of a 39-kDa tyrosine-phosphorylated protein in 18 out of 18 neutrophil samples from CML patients that was not seen in normal controls. This same protein, as assessed by two-dimensional anti-phosphotyrosine immunoblotting, was also present in cell lines expressing p210(bcr-abl), including K562 cells. Using K562 cells as a source of protein, the 39-kDa protein was purified and identified by microsequencing as Crkl, an SH2/SH3 adaptor protein related to the crk oncogene of the avian sarcoma virus, CT10. A direct interaction between Crkl and Abl has also been shown using a yeast two-hybrid screen.
UR - http://www.scopus.com/inward/record.url?scp=0028142490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028142490&partnerID=8YFLogxK
M3 - Article
C2 - 8083188
AN - SCOPUS:0028142490
SN - 0021-9258
VL - 269
SP - 22925
EP - 22928
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 37
ER -